These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4355819)

  • 1. Investigations on the correlation between abnormalities of neuromuscular transmission due to some organophosphates and activity of acetylcholinesterase in the skeletal muscle.
    Faff J; Rabsztyn T; Rump S
    Arch Toxikol; 1973 Aug; 31(1):31-8. PubMed ID: 4355819
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of fluostigmine, phospholine and compound 217 AO on abnormalities of muscle action potentials caused by complete inhibition of acetylcholinesterase.
    Faff J; Rabsztyn T; Rump S
    Acta Physiol Pol; 1975; 26(2):197-204. PubMed ID: 167546
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of excitotoxicity in organophosphorous nerve agents central poisoning.
    Solberg Y; Belkin M
    Trends Pharmacol Sci; 1997 Jun; 18(6):183-5. PubMed ID: 9226993
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of cholinesterases of rat diaphragm muscle by organophosphates and spontaneous recovery of enzyme activity in vitro.
    Welsch F; Dettbarn WD
    Biochem Pharmacol; 1972 Apr; 21(7):1039-49. PubMed ID: 5039748
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactivatability of soman-inhibited end plate cholinesterase and neuromuscular transmission.
    Murtha EF; Fleisher JH; Torre MA; Innerebner TA
    Toxicol Appl Pharmacol; 1970 Jan; 16(1):214-26. PubMed ID: 4313633
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetylcholinesterase activity in the rat tissues during chronic phospholine poisoning.
    Faff J; Borkowska G; Bak W; Raszewski W
    Acta Physiol Pol; 1975; 26(5):517-22. PubMed ID: 1224988
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylcholinesterase activity in several rat liver cell fractions after repeated poisoning with some organophosphates.
    Gajewski D
    Acta Physiol Pol; 1980; 31(5):575-80. PubMed ID: 7234437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibition by organophosphorus compounds and its clinical effects.
    Namba T
    Bull World Health Organ; 1971; 44(1-3):289-307. PubMed ID: 4941660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancuronium improves the neuromuscular transmission defect of human organophosphate intoxication.
    Besser R; Vogt T; Gutmann L
    Neurology; 1990 Aug; 40(8):1275-7. PubMed ID: 2166248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The repetitive muscular action potential in neuromuscular transmission disorders due to acetylcholinesterase inhibition].
    Besser R; Dillmann U; Gutmann L; Hopf HC
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Jun; 19(2):85-91. PubMed ID: 2841086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of some cholinolytics in organophosphate intoxications.
    Faff J; Borkowska G; Bak W
    Arch Toxicol; 1976 Oct; 36(2):139-46. PubMed ID: 1036888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nerve gas poisoning.
    Med Lett Drugs Ther; 1995 May; 37(948):43-4. PubMed ID: 7739422
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of preceding physostigmine administration on neuromuscular transmission disturbances in rats caused by dichlorphos and phospholine.
    Owczarczyk H; Gajewski D; Kisieliński T
    Acta Physiol Pol; 1980; 31(4):431-8. PubMed ID: 6255749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles.
    Kelly SS; Ferry CB; Bamforth JP
    Br J Pharmacol; 1990 Apr; 99(4):721-6. PubMed ID: 2361169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of spontaneous recovery of neuromuscular transmission after acetylcholinesterase inhibition in the rat neuromuscular junction.
    Melchers BP; Van der Laaken AL
    Brain Res; 1991 Nov; 563(1-2):49-56. PubMed ID: 1664777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The decrement-increment phenomenon in disorders of neuromuscular transmission by inhibition of acetylcholinesterase].
    Besser R; Hopf HC; Gutmann L; Dillmann U
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Mar; 20(1):28-33. PubMed ID: 2539961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and subacute organophosphate poisoning in the rat.
    De Bleecker J; Lison D; Van Den Abeele K; Willems J; De Reuck J
    Neurotoxicology; 1994; 15(2):341-8. PubMed ID: 7991223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication.
    Bueters TJ; Groen B; Danhof M; IJzerman AP; Van Helden HP
    Arch Toxicol; 2002 Nov; 76(11):650-6. PubMed ID: 12415428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of cholinesterase following poisoning with irreversible anticholinesterases: effects of theophylline and N6,O2-dibutyryl adenosine 3',5'-monophosphate on synthesis and survival.
    Stitcher DL; Harris LW; Moore RD; Heyl WC
    Toxicol Appl Pharmacol; 1977 Jul; 41(1):79-90. PubMed ID: 197659
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of organophosphates on skeletal muscle.
    Karalliedde L; Henry JA
    Hum Exp Toxicol; 1993 Jul; 12(4):289-96. PubMed ID: 8104006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.